Literature DB >> 306322

A 'profile' of immune responsiveness in multiple sclerosis.

G R Symington, I R Mackay, S Whittingham, J White, J D Buckley.   

Abstract

An 'immunological profile' of various indices of B-cell function and T-cell function was developed for the 'early' case of multiple sclerosis (MS). This was compared against two groups of controls comprising age and sex-matched healthy subjects, and patients with other disabling neurological diseases (CNS controls) who were matched for age, sex, and type and duration of disability. Some indices of humoral immune responsiveness, such as the induced primary response to monomeric flagellin and the 'resting' levels of antibody to measles and rubella viruses, showed significant augmentation. Cellular immune deficits were attributed to an illness effect per se because (a) cell-mediated immunity was depressed, but only when compared with that of healthy subjects and not when compared with that of the CNS controls, and (b) transformation responses of lymphocytes to viral antigens were inversely related to disability status. The abnormalities in humoral immune responses demonstrable in this study do not provide an explanation for this disease; if there is a relevant 'immunological fault', the nature of this needs to be sought from within the neuraxis rather than from the systemic circulation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 306322      PMCID: PMC1541226     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  41 in total

1.  T cell necessity in the pathogenesis of experimental autoimmune encephalomyelitis in mice.

Authors:  C C Bernard; J Leydon; I R Mackay
Journal:  Eur J Immunol       Date:  1976-09       Impact factor: 5.532

2.  ANTIGENS IN IMMUNITY. I. PREPARATION AND PROPERTIES OF FLAGELLAR ANTIGENS FROM SALMONELLA ADELAIDE.

Authors:  G L ADA; G J NOSSAL; J PYE; A ABBOT
Journal:  Aust J Exp Biol Med Sci       Date:  1964-06

3.  Measles antibodies in multiple sclerosis.

Authors:  J M ADAMS; D T IMAGAWA
Journal:  Proc Soc Exp Biol Med       Date:  1962-12

4.  QUANTITATIVE DETERMINATION OF SERUM IMMUNOGLOBULINS IN ANTIBODY-AGAR PLATES.

Authors:  J L FAHEY; E M MCKELVEY
Journal:  J Immunol       Date:  1965-01       Impact factor: 5.422

5.  Dermal sensitivity tests in multiple sclerosis.

Authors:  R T JOHNSON; H MILLER
Journal:  J Neurol Neurosurg Psychiatry       Date:  1963-04       Impact factor: 10.154

6.  Response of normal and multiple sclerotic subjects to typhoid-paratyphoid vaccine injections.

Authors:  E J FIELD; C A GREEN; H MILLER
Journal:  J Neurol Neurosurg Psychiatry       Date:  1961-02       Impact factor: 10.154

7.  The association of HLA antigens A3, B7, and DW2 with 330 multiple sclerosis patients in the United States.

Authors:  G Opelz; P Terasaki; L Myers; G Ellison; G Ebers; J Zabriskie; H Weiner; H Kempe; W Sibley
Journal:  Tissue Antigens       Date:  1977-01

8.  B-lymphocyte alloantigens associated with multiple sclerosis.

Authors:  D A Compston; J R Batchelor; W I McDonald
Journal:  Lancet       Date:  1976-12-11       Impact factor: 79.321

9.  Effect of encephalitogenic protein on migration in agarose of leukocytes from patients with multiple sclerosis. Variable effect of the antigen in a large dose range, with a literature review.

Authors:  B Källén; O Nilsson; C Thelin
Journal:  Acta Neurol Scand       Date:  1977-01       Impact factor: 3.209

10.  Cellular hypersensitivity in attacks of multiple sclerosis. I. A comparative study of migration inhibitory factor production and lymphoblastic transformation in response to myelin basic protein in multiple sclerosis.

Authors:  S P Colby; W Sheremata; B Bain; E H Eylar
Journal:  Neurology       Date:  1977-02       Impact factor: 9.910

View more
  8 in total

1.  Multiple sclerosis in the Orkney and Shetland Islands. II: The search for an exogenous aetiology.

Authors:  D C Poskanzer; J L Sheridan; L B Prenney; A M Walker
Journal:  J Epidemiol Community Health       Date:  1980-12       Impact factor: 3.710

2.  Multiple sclerosis in the Orkney and Shetland Islands. V: The effect on viral titres of histocompatibility determinants.

Authors:  D C Poskanzer; J L Sever; P I Terasaki; L B Prenney; J L Sheridan; M S Park
Journal:  J Epidemiol Community Health       Date:  1980-12       Impact factor: 3.710

3.  Multiple sclerosis in the Orkney and Shetland Islands. IV: Viral antibody titres and viral infections.

Authors:  D C Poskanzer; J L Sever; J L Sheridan; L B Prenney
Journal:  J Epidemiol Community Health       Date:  1980-12       Impact factor: 3.710

4.  Immunological treatment of multiple sclerosis.

Authors:  R A Hughes
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

5.  T-cell subsets in multiple sclerosis: lack of correlation between helper and suppressor T cells and the clinical state.

Authors:  J B Zabriskie; L Mayer; S M Fu; C Yeadon; V Cam; C Plank
Journal:  J Clin Immunol       Date:  1985-01       Impact factor: 8.317

6.  Delayed recovery of peripheral blood cell numbers after adjuvant cytotoxic chemotherapy for stage II breast cancer.

Authors:  M D Goodyear; I R Mackay; I S Russell
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

7.  Radioimmunoprecipitation and immunoblot studies of antibodies to rubella virus in patients with chronic liver disease.

Authors:  M B Kalvenes; K H Kalland; G Haukenes
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

8.  Tests on peripheral blood cells in multiple sclerosis.

Authors:  S McCrea; M Killen; J Thompson; W A Fleming; T A McNeill; J H Millar
Journal:  Ulster Med J       Date:  1979
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.